L-DOPA and the control of prolactin secretion.
D000238:Adenoma, Chromophobe / Q000378:metabolism; D000818:Animals; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001927:Brain Diseases / Q000378:metabolism; D001942:Breast Feeding; D001943:Breast Neoplasms / Q000188:drug therapy; D002746:Chlorpromazine / Q000494:pharmacology; D002999:Clone Cells; D003075:Coitus; D003864:Depression, Chemical; D004357:Drug Synergism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004876:Ergot Alkaloids / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D000882:Haplorhini; D006801:Humans; D007003:Hypoglycemia / Q000378:metabolism; D007031:Hypothalamus; D007980:Levodopa / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D009362:Neoplasm Metastasis; D010903:Pituitary Gland, Anterior / Q000378:metabolism; D010911:Pituitary Neoplasms / Q000378:metabolism; D011247:Pregnancy; D011388:Prolactin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D051381:Rats; D012890:Sleep; D013268:Stimulation, Chemical; D013312:Stress, Physiological / Q000378:metabolism; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology; D013997:Time Factors; D014882:Water-Electrolyte Balance
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D004791:Enzyme Inhibitors; D004876:Ergot Alkaloids; D004967:Estrogens; D007980:Levodopa; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D002746:Chlorpromazine